Chicago-based Tempus, which uses AI for drug discovery, clinical trials, and diagnostics, raised $275M in equity and debt, bringing its total funding to $1.3B+ (Keerthi Vedantam/Crunchbase News) - TechnW3

Chicago-based Tempus, which uses AI for drug discovery, clinical trials, and diagnostics, raised $275M in equity and debt, bringing its total funding to $1.3B+ (Keerthi Vedantam/Crunchbase News) - TechnW3

Keerthi Vedantam / Crunchbase News:
Chicago-based Tempus, which uses AI for drug discovery, clinical trials, and diagnostics, raised $275M in equity and debt, bringing its total funding to $1.3B+  —  This is not your average raise.  —  Biotech upstart Tempus announced on Thursday it raised $275 million through equity …

from TechnW3